tiprankstipranks
Trending News
More News >
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN

BioMarin Pharmaceutical (BMRN) Revenue

Compare
2,103 Followers

BioMarin Pharmaceutical Revenue

BioMarin Pharmaceutical had a revenue of 745.14M in the quarter ending Mar 31, 2025, with 0.94%. This bring the company's revenue in the last twelve months to 2.94B, Decreased 3.39%. In the fiscal year ending Dec 31, 2024, BioMarin Pharmaceutical had annual revenue of 2.85B with 17.97% growth.
Revenue (ttm)
2.94B
Revenue Growth
17.99%
P/S Ratio
4.03
Revenue/Employee
$938,788
Employees
3,040
Market Cap
$11.49B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
2.85B434.69M+17.97%
Dec 31, 2023
2.42B323.19M+15.42%
Dec 31, 2022
2.10B249.76M+13.53%
Dec 31, 2021
1.85B-14.18M-0.76%
Dec 31, 2020
1.86B156.41M+9.18%
Dec 31, 2019
1.70B212.84M+14.27%
Dec 31, 2018
1.49B177.57M+13.52%
Dec 31, 2017
1.31B196.79M+17.62%
Dec 31, 2016
1.12B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis